Alexander Dömlingꝉ

Author

Alexander Dömlingꝉ

Also Known As

A Dmling, A Domling, A. DOMLING, A. Domling, A. Dömling, A. S. Domling, Alex Domling, Alex S. Dömling, Alexander Domling, Alexander Dömling

579

Publications

27.6K

Citations

H-Index

142

Concepts

All Affiliations

University of Groningen Jagiellonian University University of Pittsburgh Technical University of Munich MorphoSys (Germany)

About

Alexander Dömlingꝉ is an author at University of Groningen specializing in natural sciences, organic chemistry, and chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	35	81	3.8K
2	Medicine	30	50	3.3K
3	Engineering	28	54	2.3K
4	Education	1	1	53
5	Health Sciences	1	1	13

Alexander Dömlingꝉ

210

Publications

14.7K

Citations

H-Index

Page 1

	Year	Citations
Multicomponent Reactions with Isocyanides Alexander Dömlingꝉ, Ivar Ugi Angewandte Chemie International Edition	2000	4K
Multicomponent reactions in organic chemistry Ivar Ugi, Alexander Dömlingꝉ, Werner Hörl Endeavour Organic ChemistryCross-coupling ReactionChemistryReaction Process	1994	584
Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1 Krzysztof M. Żak, Radosław Kitel, Sara Przetocka, Structure Protein FunctionApoptosisMolecular BiologyCell DeathMolecular Basis	2015	511
Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1) Krzysztof M. Żak, P. Grudnik, Katarzyna Guzik, Oncotarget	2016	413
Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1 Katarzyna Guzik, Krzysztof M. Żak, P. Grudnik, Journal of Medicinal Chemistry Drug TargetApoptosisCell DeathMolecular BiologySmall-molecule Inhibitors	2017	352
Small-molecule inhibitors of PD-1/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cells Łukasz Skalniak, Krzysztof M. Żak, Katarzyna Guzik, Oncotarget ImmunologyImmunologic MechanismAntigen ProcessingSmall-molecule InhibitorsCd4 T Cell Responses	2017	301
Since 1995 the new chemistry of multicomponent reactions and their libraries, including their heterocyclic chemistry Ivar Ugi, Alexander Dömlingꝉ, Birgit Werner Journal of Heterocyclic Chemistry Combinatorial ChemistryOther McrsChemical EngineeringUgi‐type McrsEngineering	2000	264
Structures of low molecular weight inhibitors bound to MDMX and MDM2 reveal new approaches for p53-MDMX/MDM2 antagonist drug discovery Grzegorz M. Popowicz, Anna Czarna, Siglinde Wolf, Cell Cycle P53-mdmx InteractionsDrug TargetNew ApproachesMolecular BiologyMdm2/x-p53 Interaction	2010	227
Bioactive Macrocyclic Inhibitors of the PD‐1/PD‐L1 Immune Checkpoint Katarzyna Magiera‐Mularz, Łukasz Skalniak, Krzysztof M. Żak, Angewandte Chemie International Edition	2017	182
Metabolic signature of obesity-associated insulin resistance and type 2 diabetes Haya Al‐Sulaiti, Ilhame Diboun, Maha Victor Agha, Journal of Translational Medicine	2019	172

Page 1